Skip to main content
FDA panel backs Pfizer's COVID booster for 65 and older, those at high risk
Primary tabs
•••
View
Get Stamp Tags
Published Locations
Breadcrumb
Home
FDA panel backs Pfizer's COVID booster for 65 and older, those at high risk
User login
Username
Password
Reset your password
Concept
Lead
score
COVID-19 Vaccine
1
0.65
Food and Drug Administration (FDA)
0
1
COVID-19
0
0.16
Geriatrics
0
0.16
Vaccines
0
0.16
Specialty
Lead
score
Infectious Diseases
1
1
Pharmacist
0
1
Public Health & Prevention
0
0.9
Internal Medicine
0
0.85
Pulmonary Medicine
0
0.85
Family Medicine/Primary Care
0
0.85
Hospital Medicine
0
0.25
Nursing
0
0.16